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Abstract
The pneumolysin (ply) gene is widely used as a target in PCR assays for Streptococcus pneumoniae in respiratory secretions. However,
false-positive results with conventional ply-based PCR have been reported. The aim here was to study the performance of a quantitative
ply-based PCR for the identiﬁcation of pneumococcal lower respiratory tract infection (LRTI). In a prospective study, ﬁbreoptic
bronchoscopy was performed in 156 hospitalized adult patients with LRTI and 31 controls who underwent bronchoscopy because of
suspicion of malignancy. Among the LRTI patients and controls, the quantitative ply-based PCR applied to bronchoalveolar lavage (BAL)
ﬂuid was positive at ‡103 genome copies/mL in 61% and 71% of the subjects, at ‡105 genome copies/mL in 40% and 58% of the
subjects, and at ‡107 genome copies/mL in 15% and 3.2% of the subjects, respectively. Using BAL ﬂuid culture, blood culture, and/or a
urinary antigen test, S. pneumoniae was identiﬁed in 19 LRTI patients. As compared with these diagnostic methods used in combination,
quantitative ply-based PCR showed sensitivities and speciﬁcities of 89% and 43% at a cut-off of 103 genome copies/mL, of 84% and 66%
at a cut-off of 105 genome copies/mL, and of 53% and 90% at a cut-off of 107 genome copies/mL, respectively. In conclusion, a high cut-
off with the quantitative ply-based PCR was required to reach acceptable speciﬁcity. However, as a high cut-off resulted in low sensitiv-
ity, quantitative ply-based PCR does not appear to be clinically useful. Quantitative PCR methods for S. pneumoniae using alternative
gene targets should be evaluated.
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Introduction
In lower respiratory tract infection (LRTI), identiﬁcation of
the aetiological agent can be useful for the selection of appro-
priate antimicrobial therapy [1]. Streptococcus pneumoniae is
a major cause of severe LRTI [2,3]. However, a problem in
clinical practice is that conventional cultures may give false-
negative results for S. pneumoniae [3,4], especially in patients
receiving ongoing antibiotic treatment [5]. Thus, for improve-
ment of the diagnostic possibilities, nucleic acid detection
methods have been developed for S. pneumoniae [6].
One of the most widely used PCR targets in S. pneumoniae
is the pneumolysin (ply) gene [7–10]. However, speciﬁcity
problems have been encountered with ply-based PCR. In two
studies [11,12], conventional ply-based PCR applied to upper
respiratory tract specimens was reported to give positive
results in 58% and 73%, respectively, of healthy adult con-
trols. Carriage of S. pneumoniae cannot explain these ﬁgures,
as the carriage rate is low among adults in western countries
[13,14]. Instead, a suggested explanation is false ply-based
PCR positivity due to a-haemolytic streptococci [6], which
are normally present in the respiratory ﬂora. Streptococci
such as Streptococcus mitis and Streptococcus oralis sometimes
contain a ply gene [15–18].
In spite of these documented speciﬁcity problems, ply-
based PCR is frequently used [9,10]. It has been assumed
that ply-based PCR may be clinically useful, if quantitative
PCR with appropriate cut-off limits is used and if the meth-
ods are applied to secretions from the lower respiratory
tract [8,19]. However, so far, this assumption has not been
tested appropriately.
The aim of the present study was to test the performance
of a quantitative ply-based PCR applied to bronchoalveolar
lavage (BAL) ﬂuid for the identiﬁcation of pneumococcal LRTI.
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Materials and Methods
Subjects
One hundred and ﬁfty-nine consecutively identiﬁed immuno-
competent adult patients who were hospitalized because of
LRTI at the Department of Internal Medicine, Silkeborg
County Hospital, Silkeborg, Denmark, between September
1997 and August 2000, were enrolled in a prospective study.
The criteria for LRTI were fever and/or an increased leuko-
cyte count (‡11 · 109/L), together with increased focal
symptoms from the lower airways with at least one of three
newly developed symptoms of increased dyspnoea, increased
coughing, and/or increased sputum purulence.
BAL ﬂuid was available from 156 patients (median age,
63 years; range, 26–90 years), who were included in the
present study. These patients have been described previously
[20]. A chronic lung disease was documented in 72 patients
(46%), 31% were current smokers, and 40% were previous
smokers. New inﬁltrates were identiﬁed on chest X-ray ﬁlms
for 87 patients (56%). Antibiotics had been taken within
7 days prior to bronchoscopy in 103 cases (66%).
As controls, 31 adult patients (median age, 64 years;
range, 30–77 years), who consecutively underwent bron-
choscopy for suspected malignancy and who did not have
pulmonary infection were included. Nineteen of them had
lung malignancies, and 12 had no pathology identiﬁed by
bronchoscopy or radiological examination. Twenty-seven
controls (87%) were current or previous smokers.
Bronchoscopy and BAL ﬂuid
The patients and controls underwent standardized ﬁbreoptic
bronchoscopy (FOB) with BAL [21] within 24 h of admission.
In short, the ﬁbreoptic bronchoscope was introduced
through the nose or through the mouth. The tip of the bron-
choscope was wedged into the segment of bronchus affected
by a pulmonary inﬁltrate, or, if no inﬁltrate was available, into
the middle lobe. A sterile, thin tube was then introduced into
the working channel of the bronchoscope, and lavage was
then performed. One to three portions of 60 mL of isotonic
NaCl were used for lavage, and the aspirated ﬂuid was col-
lected in one single portion for microbiological analyses.
Conventional microbiological investigations
BAL ﬂuid was analysed by culture at the Department of Clini-
cal Microbiology, Aarhus University Hospital, Aalborg, Den-
mark within a maximum of 6 h from sampling. The specimens
were cultured on horse blood (5%) agar with semiquantitative
determination following dispersion of 1 and 10 lL each on
one half of the plate. The plates were incubated in carbon
dioxide (5%) at 35C for 24–48 h. Bacterial identiﬁcation was
performed according to standard microbiological methods.
S. pneumoniae was identiﬁed on the basis of colony morphol-
ogy and optochin sensitivity. a-Haemolytic streptococci were
identiﬁed in BAL culture, but were not subtyped. The cut-off
limit for a positive BAL culture result was 102 CFUs/mL of
sample. After culture, the BAL ﬂuid was frozen at )20C.
Blood culturing was performed with a Bactec blood-cul-
turing system at the Department of Clinical Microbiology,
Aarhus University Hospital. Urine samples were sent imme-
diately to the Statens Serum Institute, Copenhagen, Den-
mark, and were analysed for pneumococcal urinary antigen
by countercurrent immunoelectrophoresis [22]. This assay
detects capsular polysaccharides, in contrast to the Binax
NOW assay, which detects C polysaccharide.
PCR
The frozen BAL samples from the LRTI patients and controls
were sent to the Department of Clinical Microbiology, O¨re-
bro University Hospital, O¨rebro, Sweden, for DNA extrac-
tion and lytA-based PCR in 2003–2004. Extracted DNA was
stored and was sent to the Department of Clinical
Microbiology, Uppsala University Hospital, Uppsala, Sweden,
for quantitative ply-basedPCR in 2007.
DNA extraction. DNA from 0.2–0.5 mL of BAL ﬂuid was
extracted using the automatic MagNa Pure LC DNA-Isola-
tion system (Roche Diagnostics). DNA used for determina-
tion of the detection capacity of the ply-based PCR was
puriﬁed using the Qiagen DNA mini kit (Qiagen, Hilden,
Germany) and the concentration of DNA was determined
using a Nanodrop instrument (NanoDrop Technologies, Inc.
Wilmington, DE, USA). The genome copy number was
determined according to conventional calculations based on
molecular weight and one gene copy per genome.
LytA-based PCR. LytA-based PCR was performed as previously
described [23]. In short, extracted DNA (10 lL) was added
to a PCR mixture containing the lytA primers 5¢-CGG
ACTACCGCCTTTATATCG-3¢ and 5¢-GTTTCAATCG
TCAAGCCGTT-3¢. After 40 cycles, PCR products were
detected by electrophoresis on an agarose gel containing
ethidium bromide. A positive and negative control was
included in all PCRs. To test for PCR inhibition, DNA (8 lL)
extracted from a PCR-negative sample was spiked with 2 lL
of DNA extracted from S. pneumoniae (CCUG 36696), as
previously described [23], and the PCR was repeated.
Ply-based PCR. The quantitative real-time PCR for ply was
used as described by Corless et al. [24], except that
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3.5 mmol/L MgCl2 was used instead of 5.5 mmol/L, and the
elongation time was 40 s instead of 1 min. The following
primers and probe were derived from a previously
sequenced ply gene (S. pneumoniae strain NCTC 7466,
GenBank accession number X52474): primer Pnc ply F, 5¢-
TGCAGAGCGTCCTTTGGTCTAT-3¢ (position 894–915);
and primer Pnc ply R, 5¢-CTCTTACTCGTGGTTTCCAAC
TTG-3¢ (position 974–950). These deﬁned an amplicon of
80 bp. A Cy5-labeled probe (5¢-TGGCGCCCATAAGCAA
CACTCGAA-3¢) with black hole quencher was used. The
primers and probe were obtained from Thermo Hybaid,
Interactive Division (Ulm, Germany). In short, the opti-
mized real-time PCR ampliﬁcations were performed in a
25-lL reaction volume, containing 0.3 lmol/L of each pri-
mer, 0.2 lmol/L of the probe, 3.5 mmol/L MgCl2,
0.2 mmol/L dNTP, and 1 U of HotStar Taq polymerase
(Qiagen). In the assay, 5 lL of extracted DNA was used.
The PCR was performed in a Rotor-Gene 3000 instru-
ment (Corbett Research, Mortlake, Sydney, Australia),
according to the following program: 15 min of enzyme
activation at 95C, followed by 45 cycles of 94C for
15 s, and 60C for 40 s. A positive control (S. pneumoniae
CCUG 28588) and a negative control were included
in all PCRs. Standard curves for quantiﬁcation were based
on duplicates of three measured points with 500, 2000
and 10 000 genome copies per PCR reaction of the ply
target.
The detection capacity of the ply-based PCR was deter-
mined with serial dilutions of target DNA in carrier tRNA
(1 lg/mL). Two experiments were performed, with 5–600
genome copies per reaction tube and two to four tubes at
each dilution.
The reproducibility was evaluated by testing DNA prepa-
rations with known concentrations (duplicates of 500, 2000
and 10 000 genome copies per PCR) in ﬁve consecutive
runs.
Reference standard for pneumococcal aetiology
Our reference standard for pneumococcal aetiology was
based on a combination of blood culture, urinary antigen
test, and BAL culture with a cut-off of 104 CFUs/mL. If at
least one of these tests gave a positive result, the reference
standard was considered positive. If none of the tests gave a
positive result, the reference standard was considered nega-
tive.
Ethics
The study was performed according to the Declaration of
Helsinki II and approved by the local ethical committee; all
participating patients gave written consent.
Statistics
The chi-square test was used for comparison of proportions.
A p-value of <0.05 was considered to be signiﬁcant.
Results
Detection limit and reproducibility of the ply-based PCR
Serial dilutions of target DNA of known concentration were
tested to identify the detection capacity of the quantitative
ply assay. The detection limit was 20 genome copies per
reaction, which equals 103 genome copies/mL. Three known
concentrations of the target DNA were tested in duplicate
in ﬁve consecutive runs (mean of ten tubes for each concen-
tration) to evaluate the reproducibility of the quantitative ply
assay. For the concentration of 10 000 copies per reaction,
the cycle of threshold value ranged from 27.2 to 27.7 cycles
(average, 27.5 cycles), and the calculated concentration ran-
ged from 9824 to 11 413 copies per reaction (average,
10 654 copies per reaction). For 2000 copies per reaction,
the corresponding cycle of threshold values and copy num-
bers were 30.1–31.3 (average, 30.4) and 1431–2588 (average,
2020), respectively. For 500 copies per reaction, the corre-
sponding values were 32.3–34.4 (average, 32.9) and 317–817
(average, 504), respectively.
Results concerning the patients with LRTI
Table 1 shows the frequencies of positive results of the dif-
ferent tests for S. pneumoniae, and Table 2 shows the differ-
ent result combinations of the LRTI patients. According to
the combined reference standard, 19 patients had pneumo-
coccal LRTI.
TABLE 1. Positive test results for Streptococcus pneumoniae
in patients with lower respiratory tract infection (LRTI) and
controls
Test Cut-off limit
LRTI
(n = 156), no.
(%) positive
Controls
(n = 31),
no. (%)
positive
Blood culturea ND 6 (3.9) NI
Urinary antigen testb ND 9 (6.3) NI
BAL ﬂuid culture ‡102 CFUs/mL 10 (6.4) 2 (6.5)
‡104 CFUs/mL 7 (4.4) 0
BAL lytA-based PCR ND 44 (28) 4 (13)
BAL ply-based PCR ‡103 genome copies/mL 95 (61) 22 (71)
‡104 genome copies/mL 84 (54) 22 (71)
‡105 genome copies/mL 63 (40) 18 (58)
‡106 genome copies/mL 41 (26) 7 (23)
‡107 genome copies/mL 24 (15) 1 (3.2)
‡108 genome copies/mL 2 (1.3) 0
ND, not deﬁned; NI, not investigated; BAL, bronchoalveolar lavage.
aOne hundred and ﬁfty-two LRTI patients were tested.
bOne hundred and forty-two LRTI patients were tested.
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Altogether, ply DNA was found in BAL ﬂuid from 95
patients. In Fig. 1, the quantitative data of ply-based PCR are
presented in relation to the reference standard and lytA-
based PCR. Among the 109 LRTI patients with negative ref-
erence standard and negative lytA-based PCR results, ply
DNA was detected in 51 (47%), 27 of whom had taken anti-
biotics prior to FOB.
Among the 103 LRTI patients who had taken antibiotics
prior to FOB, the combined reference standard was positive
in 11 cases, lytA-based PCR was positive in 32 cases, and ply-
based PCR was positive in 58 cases.
Table 3 shows the performance of the quantitative
ply-based PCR at different cut-offs. Although the negative
predictive values were high, the positive predictive values
for detection of pneumococcal LRTI were low. At a cut-off
of ‡107 genome copies/mL, a speciﬁcity of 90% was
obtained, but the sensitivity dropped to 53%. For compari-
son, the lytA-based PCR had a sensitivity of 84% (16/19) and
a speciﬁcity of 80% (109/137). Analysis of the receiver oper-
ating characteristic curve for the quantitative ply-based PCR
showed an area under the curve of 0.807 (95% CI 0.695–
0.920).
a-Haemolytic streptococci were identiﬁed after culture of
BAL ﬂuid from 69 LRTI patients (44%). Among 135 patients
in whom S. pneumoniae was not detected after BAL ﬂuid cul-
ture, blood culture, or urinary antigen tests, those with and
without a-haemolytic streptococci were, at similar frequen-
cies, ply-based PCR-positive (61% (39/64) vs. 52% (37/71);
TABLE 2. Combined results of tests
for Streptococcus pneumoniae in 156
patients with lower respiratory
tract infection
Blood
culture
Urinary
antigen
test
BAL culture,
cut-off ‡104
CFUs/mL
BAL
lytA-based
PCR
BAL ply-based
PCR, cut-off
‡103 copies/mL
Number of patients
to whom the results
of all preceeding
columns apply
+ + ) + + 2
+ + ) + ) 1
+ ND ) + + 1
+ ) ) + + 2
ND + ) + + 1
) + ) + + 3
) + ) ) + 1
) + ) ) ) 1
) ) + + + 6
) ) + ) + 1
ND ) ) + + 2
) ND ) + + 3
) ) ) + + 22
) ) ) + ) 1
) ND ) ) + 8
) ) ) ) + 43
) or NDa ) or NDb ) ) ) 58
BAL, bronchoalveolar lavage; ND, not done.
aND, n = 1.
bND, n = 2.
Reference
lytA PCR + or –
Patients with lower respiratory tract infection Control patients 
(n = 19)
standard +
Reference 
lytA PCR +
(n = 28) 
standard –
Reference 
lytA PCR –
lytA PCR +
(n = 109)
(n = 5) 
standard –
Culture + or 
lytA PCR –
(n = 26) 
Culture – 
Negative 
109 
108 
107 
106 
105 
104 
103 
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y 
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n
o
m
e 
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FIG. 1. Quantitative results of ply-based
PCR applied to bronchoalveolar lavage
ﬂuid in 156 patients with lower respira-
tory tract infection (LRTI) and 31 con-
trols, related to the results of other
diagnostic tests. The reference standard
of the LRTI patients was considered
positive when at least one reference
test (blood culture, urinary antigen test,
or culture of bronchoalveolar lavage
ﬂuid, cut-off 104 CFUs/mL) gave a posi-
tive result, and negative when no refer-
ence test gave a positive result. In the
control group, the cut-off of culture was
102 CFUs/mL.
568 Clinical Microbiology and Infection, Volume 15 Number 6, June 2009 CMI
ª2009 The Authors
Journal Compilation ª2009 European Society of Clinical Microbiology and Infectious Diseases, CMI, 15, 565–570
p 0.30, chi-square test) and lytA-based PCR-positive (16%
(10/64) vs. 23% (16/71); p 0.31).
Results concerning the control patients
Table 1 shows S. pneumoniae detection among the 31
controls. BAL ﬂuid culture was positive in two cases.
LytA-based PCR was positive in one of them and in three
additional controls. BAL culture and/or lytA-based PCR gave
positive results in two controls with lung malignancy and in
three controls with no pathology identiﬁed. Ply-based PCR
was positive in these ﬁve cases and additionally in 17 con-
trols. Altogether, ply DNA was detected in 12 cases with
lung malignancy and in ten cases with no pathology identi-
ﬁed. The quantitative ply-based PCR results are shown in
Fig. 1.
Discussion
Although a quantitative PCR technique and lower respiratory
tract samples were used, the speciﬁcity problems with ply-
based PCR could not be solved in the present study. In line
with previous studies [11,12], there were similar positivity
rates for ply-based PCR at the different cut-offs in LRTI
patients and controls. The performance analysis of the quan-
titative ply-based PCR (Table 3) showed that a cut-off of
107 genome copies/mL was required for an acceptable speci-
ﬁcity. At that cut-off, there was a higher positivity rate with
quantitative ply-based PCR than with BAL culture (Table 1),
but the sensitivity was low. Thus, no particular cut-off could
make this method clinically useful.
The results of the present study are in agreement with
the previous documentation of the non-speciﬁcity of ply-
based PCR for the detection of pneumococcal LRTI [6]. It is
important to note that non-speciﬁcity of detection using
PCR has not been restricted to a single target sequence in
the ply gene, but has been observed in several PCR studies
in which different primer pairs have been used [15,24–27].
The question then arises of whether the a-haemolytic
streptococci are responsible for the false-positive ply-based
PCR results, as has been assumed [6]. In the present study,
we could not ﬁnd any correlation between the presence of
a-haemolytic streptococci in BAL ﬂuid culture and ply-based
PCR positivity. As the a-haemolytic streptococci isolated
were not typed to species level, we have no information
on whether ply positivity was correlated with any particular
species.
However, the ply-based PCR, as used here, recently
yielded positive results with three of eight S. mitis isolates
and with two of two Streptococcus pseudopneumoniae isolates,
but negative results with 21 other isolates of a-haemolytic
streptococci belonging to 11 different species [28]. These
data are in agreement with those from other studies [16,18],
and indicate that only the streptococcal species most closely
related to S. pneumoniae may harbour the ply gene, whereas
the remaining a-haemolytic streptococci do not. To our
knowledge, the carriage rate of these species in the human
respiratory tract has not been studied. Their importance for
the false-positive results in the previous PCR studies target-
ing ply [11,12] is not known. However, the absence of corre-
lation between a-haemolytic streptococci in BAL ﬂuid
culture and ply-based PCR positivity in the present study
indicates that streptococci of the respiratory tract ﬂora may
not be the only reason for positive ply-based PCR results in
samples devoid of S. pneumoniae. This leads to the question
of whether the speciﬁcity problems encountered with ply-
based PCR should discourage the application of PCR to
respiratory tract secretions for the establishment of the diag-
nosis of pneumococcal LRTI. The answer to this should
probably be no, as in vitro studies [15–17,29] have shown
that some gene targets, e.g. lytA, are more speciﬁc for S. pneu-
moniae than ply. As previously discussed [20], the conven-
tional lytA-based PCR of the present study could be a useful
complement to BAL ﬂuid culture in patients who have taken
antibiotics prior to bronchoscopy. A quantitative lytA-based
PCR would probably be even more clinically useful.
Another gene target that has been shown to be speciﬁc
for S. pneumoniae is the Spn9802 fragment [12,17]. For this
gene target, we have developed a quantitative real-time PCR
[28], which showed promising results when applied to naso-
pharyngeal aspirates from pneumonia patients and controls.
TABLE 3. Performance of quantitative ply-based PCR at
different detection limits applied to bronchoalveolar lavage
(BAL) ﬂuid for identiﬁcation of pneumococcal aetiology in
lower respiratory tract infection
Ply-based PCR
cut-off (genome
copies/mL) Sensitivitya Speciﬁcityb
Positive
predictive
valuec
Negative
predictive
valued
‡103 89 (17/19) 43 (59/137) 18 (17/95) 97 (59/61)
‡104 89 (17/19) 51 (70/137) 20 (17/84) 97 (70/72)
‡105 84 (16/19) 66 (90/137) 25 (16/63) 97 (90/93)
‡106 68 (13/19) 80 (109/137) 32 (13/41) 95 (109/115)
‡107 53 (10/19) 90 (123/137) 42 (10/24) 93 (123/132)
‡108 5.3 (1/19) 99 (136/137) 50 (1/2) 88 (136/154)
Blood culture, urinary antigen test and BAL culture (cut-off 104 CFUs/mL) were
used as reference tests.
aReported as percentage (number with positive PCR/number with any reference
test positive).
bReported as percentage (number with negative PCR/number with no reference
test positive).
cReported as percentage (number with any reference test positive/number with
positive PCR).
dReported as percentage (number with no reference test positive/number with
negative PCR).
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In a future study, this quantitative Spn9802 PCR will be
applied to the BAL ﬂuid samples analysed here.
In conclusion, a high cut-off of the quantitative ply-based
PCR was required to obtain an acceptable speciﬁcity. How-
ever, as a high cut-off resulted in a low sensitivity, quantita-
tive ply-based PCR does not appear to be clinically useful.
Quantitative PCR methods for S. pneumoniae using alterna-
tive gene targets should be evaluated.
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